Viewing Study NCT07075718


Ignite Creation Date: 2025-12-25 @ 5:00 AM
Ignite Modification Date: 2025-12-26 @ 4:00 AM
Study NCT ID: NCT07075718
Status: RECRUITING
Last Update Posted: 2025-07-22
First Post: 2025-07-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Sponsor: Glaukos Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module